Holocene Advisors
PFE icon

Holocene Advisors’s Pfizer PFE Stock Holding History

Holocene Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-800,000
Closed -$20.3M – 850
2025
Q1 		$20.3M Buy
+800,000
New +$20.9M 0.06% 240
2021
Q1 		– Sell
-24,951
Closed -$918K – 915
2020
Q4 		$918K Buy
+24,951
New +$915K 0.01% 562
2018
Q2 		– Sell
-7,226
Closed -$243K – 692
2018
Q1 		$243K Sell
7,226
-19,129
-73% -$658K 0.01% 466
2017
Q4 		$906K Buy
+26,355
New +$899K 0.02% 203

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Holocene Advisors's PFE Position: Q2 2025 in Review

Holocene Advisors sold out of Pfizer (PFE) in Q2 2025, closing a stake of 800,000 shares — an estimated $20.3M sold.

Holocene Advisors first reported a position in PFE in Q4 2017 and held it in 4 quarters. The position peaked at $20.3M in Q1 2025. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Holocene Advisors reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Holocene Advisors sold 800,000 Pfizer shares in Q2 2025, an estimated $20.3M.
  • Holocene Advisors first reported a position in Pfizer in Q4 2017 and held it in 4 quarters.
  • Holocene Advisors's Pfizer position peaked at $20.3M in Q1 2025.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Holocene Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.